Literature DB >> 3339141

Adverse reactions to acyclovir: topical, oral, and intravenous.

K A Arndt1.   

Abstract

Overall, acyclovir is a remarkably safe drug considering its potent antiviral effect. The most frequent reactions with short-term use of oral acyclovir are nausea and vomiting and with 6 months' use headache, diarrhea, nausea, and vomiting. These symptoms are also seen frequently with placebos. The most frequent adverse reaction to intravenous use has been inflammation and phlebitis at the injection site. The two most important serious adverse effects are (1) encephalopathic changes with abnormal electroencephalograms and lethargy, tremors, confusion, and seizures and (2) renal precipitation of the drug because of a rapid bolus of drug administered parenterally. Safety of acyclovir for use during pregnancy and in neonates and young children has not been established.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3339141     DOI: 10.1016/s0190-9622(88)70025-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Water-soluble, solution-stable, and biolabile N-substituted (aminomethyl)benzoate ester prodrugs of acyclovir.

Authors:  H Bundgaard; E Jensen; E Falch
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

Review 2.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

3.  Stevens-Johnson syndrome-toxic epidermal necrolysis: a fatal cutaneous adverse reaction to oral acyclovir.

Authors:  Subhra Sankar Sen; Abheek Sil; Uddalak Chakraborty; Atanu Chandra
Journal:  BMJ Case Rep       Date:  2020-08-26

4.  Myricetin inhibits pseudorabies virus infection through direct inactivation and activating host antiviral defense.

Authors:  Huaiyue Hu; Zhiqiang Hu; Yingying Zhang; Hongping Wan; Zhongqiong Yin; Lixia Li; Xiaoxia Liang; Xinghong Zhao; Lizi Yin; Gang Ye; Yuan-Feng Zou; Huaqiao Tang; Renyong Jia; Yaqin Chen; Hao Zhou; Xu Song
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

5.  Herbal Gel Formulation Developed for Anti-Human Immunodeficiency Virus (HIV)-1 Activity Also Inhibits In Vitro HSV-2 Infection.

Authors:  Nripendra Nath Mishra; Ajay Kesharwani; Aakanksha Agarwal; Suja Kizhiyedath Polachira; Reshmi Nair; Satish Kumar Gupta
Journal:  Viruses       Date:  2018-10-24       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.